-
1
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
2
-
-
0031733360
-
Hyperlipidemia in patients with chronic renal disease
-
Kasiske BL. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S142-56. (Pubitemid 28527270)
-
(1998)
American Journal of Kidney Diseases
, vol.32
, Issue.5 SUPPL. 3
-
-
Kasiske, B.L.1
-
3
-
-
84865602423
-
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: A population-level cohort study
-
Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380:807-14.
-
(2012)
Lancet
, vol.380
, pp. 807-814
-
-
Tonelli, M.1
Muntner, P.2
Lloyd, A.3
Manns, B.J.4
Klarenbach, S.5
Pannu, N.6
-
4
-
-
83055172414
-
K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease
-
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
-
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis. 2003;41(Suppl 3):S1-77.
-
(2003)
Am J Kidney Dis
, vol.41
, Issue.SUPPL. 3
-
-
-
5
-
-
0031738068
-
Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
-
Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on cardiovascular disease. Am J Kidney Dis. 1998;32:853-906. (Pubitemid 28516321)
-
(1998)
American Journal of Kidney Diseases
, vol.32
, Issue.5
, pp. 853-906
-
-
Levey, A.S.1
Beto, J.A.2
Coronado, B.E.3
Eknoyan, G.4
Foley, R.N.5
Kasiske, B.L.6
Klag, M.J.7
Mailloux, L.U.8
Manske, C.L.9
Meyer, K.B.10
Parfrey, P.S.11
Pfeifer, M.A.12
Wenger, N.K.13
Wilson, P.W.F.14
Wright Jr., J.T.15
Willis, K.16
-
6
-
-
33749035484
-
Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control
-
DOI 10.1001/archinte.166.17.1884
-
Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006;166:1884-91. (Pubitemid 44455172)
-
(2006)
Archives of Internal Medicine
, vol.166
, Issue.17
, pp. 1884-1891
-
-
Parikh, N.I.1
Hwang, S.-J.2
Larson, M.G.3
Meigs, J.B.4
Levy, D.5
Fox, C.S.6
-
7
-
-
0035127168
-
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
-
Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001;37:484-9. (Pubitemid 32195286)
-
(2001)
American Journal of Kidney Diseases
, vol.37
, Issue.3
, pp. 484-489
-
-
Tonelli, M.1
Bohm, C.2
Pandeya, S.3
Gill, J.4
Levin, A.5
Kiberd, B.A.6
-
8
-
-
84865658424
-
Lipid-lowering therapy in persons with chronic kidney disease: A systematic review and meta-analysis
-
Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157:251-62.
-
(2012)
Ann Intern Med
, vol.157
, pp. 251-262
-
-
Upadhyay, A.1
Earley, A.2
Lamont, J.L.3
Haynes, S.4
Wanner, C.5
Balk, E.M.6
-
9
-
-
84865628946
-
Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-analysis
-
Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012;157:263-75.
-
(2012)
Ann Intern Med
, vol.157
, pp. 263-275
-
-
Palmer, S.C.1
Craig, J.C.2
Navaneethan, S.D.3
Tonelli, M.4
Pellegrini, F.5
Strippoli, G.F.6
-
10
-
-
41449093519
-
Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials
-
DOI 10.1136/bmj.39472.580984.AE
-
Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ. 2008;336:645-51. (Pubitemid 351481234)
-
(2008)
BMJ
, vol.336
, Issue.7645
, pp. 645-651
-
-
Strippoli, G.F.M.1
Navaneethan, S.D.2
Johnson, D.W.3
Perkovic, V.4
Pellegrini, F.5
Nicolucci, A.6
Craig, J.C.7
-
11
-
-
3042651139
-
Grading quality of evidence and strength of recommendations
-
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
-
(2004)
BMJ
, vol.328
, pp. 1490
-
-
Atkins, D.1
Best, D.2
Briss, P.A.3
Eccles, M.4
Falck-Ytter, Y.5
Flottorp, S.6
-
12
-
-
33845343267
-
Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
-
DOI 10.1038/sj.ki.5001875, PII 5001875
-
Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;70:2058-65. (Pubitemid 44871367)
-
(2006)
Kidney International
, vol.70
, Issue.12
, pp. 2058-2065
-
-
Uhlig, K.1
MacLeod, A.2
Craig, J.3
Lau, J.4
Levey, A.S.5
Levin, A.6
Moist, L.7
Steinberg, E.8
Walker, R.9
Wanner, C.10
Lameire, N.11
Eknoyan, G.12
-
13
-
-
84874026581
-
The management of dyslipidemia in CKD: New analyses of an expanding dataset
-
Kasiske BL, Wheeler DC. The management of dyslipidemia in CKD: new analyses of an expanding dataset. Am J Kidney Dis. 2013;61:371-4.
-
(2013)
Am J Kidney Dis
, vol.61
, pp. 371-374
-
-
Kasiske, B.L.1
Wheeler, D.C.2
-
14
-
-
84883464989
-
LDL cholesterol in CKD - To treat or not to treat?
-
Massy ZA, de Zeeuw D. LDL cholesterol in CKD - to treat or not to treat? Kidney Int. 2013;84:451-6.
-
(2013)
Kidney Int
, vol.84
, pp. 451-456
-
-
Massy, Z.A.1
De Zeeuw, D.2
|